Hedge Fund - Casdin Capital

Alnylam Pharmaceuticals Inc. (ALNY) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2024 - Q2 (2024-06-30) $41,310,000 3.16% 170,000 $157.87
2 2024 - Q1 (2024-03-31) $53,503,100 3.97% 358,000 $166.82
3 2023 - Q4 (2023-12-31) $37,324,950 3.66% 195,000 $170.34
4 2023 - Q3 (2023-09-30) $35,420,000 3.92% 200,000 $191.12
5 2023 - Q2 (2023-06-30) $53,183,200 4.64% 280,000 $198.26
6 2023 - Q1 (2023-03-31) $54,086,400 4.45% 270,000 $210.20
7 2022 - Q4 (2022-12-31) $86,742,250 6.72% 365,000 $213.29
8 2022 - Q3 (2022-09-30) $129,704,000 8.52% 648,000 $190.74
9 2022 - Q2 (2022-06-30) $117,409,000 9.92% 805,000 $141.87
10 2022 - Q1 (2022-03-31) $163,290,000 7.32% 1,000,000 $152.35
11 2021 - Q4 (2021-12-31) $169,580,000 4.77% 1,000,000 $185.86
12 2021 - Q3 (2021-09-30) $188,810,000 4.69% 1,000,000 $187.58
13 2021 - Q2 (2021-06-30) $169,520,000 4.3% 1,000,000 $146.46
14 2021 - Q1 (2021-03-31) $124,247,000 3.7% 880,000 $150.49
15 2020 - Q4 (2020-12-31) $101,377,000 3% 780,000 $133.53
16 2020 - Q3 (2020-09-30) $90,272,000 4.04% 620,000 $142.11
17 2020 - Q2 (2020-06-30) $81,461,000 4.82% 550,000 $134.81
18 2020 - Q1 (2020-03-31) $63,677,000 6.75% 585,000 $115.43
19 2019 - Q4 (2019-12-31) $59,313,000 5.45% 515,000 $99.70
20 2019 - Q3 (2019-09-30) $48,252,000,000 4.99% 600,000 $79.11
21 2019 - Q2 (2019-06-30) $47,164,000,000 4.41% 650,000 $76.72
22 2019 - Q1 (2019-03-31) $41,585,000 4.56% 445,000 $83.64
23 2018 - Q4 (2018-12-31) $25,883,000 4.42% 355,000 $76.92
24 2018 - Q3 (2018-09-30) $23,630,000 2.87% 270,000 $100.59
25 2018 - Q2 (2018-06-30) $26,592,000 3.71% 270,000 $99.19
26 2018 - Q1 (2018-03-31) $29,775,000 5.23% 250,000 $128.92
27 2017 - Q4 (2017-12-31) $25,410,000 6.18% 200,000 $125.65
28 2017 - Q3 (2017-09-30) $23,498,000 6.63% 200,000 $85.36
29 2017 - Q2 (2017-06-30) $8,375,000 3.09% 105,000 $63.91
30 2017 - Q1 (2017-03-31) $2,819,000 1.66% 55,000 $46.22
31 2016 - Q4 (2016-12-31) $3,182,000 2.62% 85,000 $41.87
32 2016 - Q3 (2016-09-30) $2,643,000 2.14% 39,000 $70.55
33 2016 - Q2 (2016-06-30) $4,023,000 4% 72,500 $63.00
34 2016 - Q1 (2016-03-31) $5,649,000 6.48% 90,000 $66.49
35 2015 - Q4 (2015-12-31) $5,648,000 4.99% 60,000 $92.72

The displayed share prices are average quarterly stock market prices.